Long-term outcomes after sepsis treatment
Treatments studied
Part of Infections clinical trials.
This study looks at what happens long-term to people who had sepsis and were treated, then went home after recovering. It may help doctors better predict recovery and plan follow-up care after hospitalization.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had sepsis and were part of the TESTS study
- You were discharged (released) from the hospital after you recovered
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether thymosin alpha-1, an immune-boosting medicine, can help people with stage I non-small cell lung cancer after surgery. The goal is to see if it improves the immune system's response and recovery.
This trial looks at whether thymosin-alpha 1, an immune-support treatment, can help prevent colon cancer from coming back after surgery. It targets people with high-risk stage II or III colon cancer who have had the tumor removed.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at how sepsis (a severe infection that can affect the whole body) affects children after they leave the intensive care unit. It compares children who had sepsis to those with other critical illnesses to understand long-term health.
This study follows up with patients who had sepsis in the ICU to understand their long-term health outcomes. It may help improve care for future patients.
This trial is testing several different treatments to find the best one for each person with sepsis. It looks at specific 'treatable traits' like inflammation, blood clotting problems, or immune system issues to match you with the right therapy. The goal is to improve recovery and survival.
Hear when a new Long-term Effects of Thymosin Alpha 1 Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.